medical device company focused on innovative endoscopic procedures and devices. medigus developed an entire endoscopic system for intraluminal treatment of gerd (gastroesophageal reflux disease), one of the most common chronic diseases in the western world. the endoscopic system for the treatment of gerd - the srs - combines a miniaturized video camera, a surgical stapler and ultrasonic sights for alignment in a single instrument. the srs system and its unique flexible endoscope allows gastroenterologists and surgeons to perform endoluminally a true partial anterior fundoplication, thereby revolutionizing the treatment of gerd by eliminating the need for open or laparoscopic surgery - the current standard practice for treating severe gerd. shifting the gerd treatment from surgery to an endoluminal procedure, without opening the abdominal cavity, is a revolution. in addition, medigus designs and manufactures endoscopy systems for partner companies based on its proprietary technologies,
Company profile
Ticker
XYLO
Exchange
Website
CEO
Liron Carmel
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
XYLO stock data
Latest filings (excl ownership)
6-K
Xylo Technologies Files its 2023 Annual Report on Form 20-F
22 Apr 24
20-F
2023 FY
Annual report (foreign)
22 Apr 24
6-K
Report of Foreign Private Issuer
15 Apr 24
424B3
Prospectus supplement
15 Apr 24
6-K
Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its Business
9 Apr 24
6-K
Report of Foreign Private Issuer
27 Mar 24
6-K
Installment of its Wireless Charging System for Automatic
19 Mar 24
6-K
Report of Foreign Private Issuer
7 Mar 24
6-K
As part of the ongoing collaboration with Vayu Aerospace, ParaZero’s safety systems will be integrated into Vayu’s fleet of delivery drones
22 Feb 24
6-K
Report of Foreign Private Issuer
12 Feb 24
Latest ownership filings
SC 13G
ParaZero Technologies Ltd.
14 Feb 24
SC 13G/A
Clearmind Medicine Inc.
5 Sep 23
SC 13G
Clearmind Medicine Inc.
9 Feb 23
SC 13D
Jeffs' Brands Ltd
13 Sep 22
SC 13D
FUEL DOCTOR HOLDINGS, INC.
4 Apr 22
SC 13G/A
Citadel Securities GP LLC
16 Feb 21
SC 13G/A
Empery Asset Management, LP
28 Jan 21
SC 13G/A
SABBY MANAGEMENT, LLC
7 Jan 21
SC 13G
SABBY MANAGEMENT, LLC
11 Dec 20
SC 13G
Citadel Securities GP LLC
26 Oct 20
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
68.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 12 |
Opened positions | 7 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 41.50 mm |
Total shares | 7.00 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
L.I.A. Pure Capital | 6.60 mm | $20.80 mm |
Citadel Securities GP | 169.82 k | $324.00 k |
Armistice Capital | 85.71 k | $5.06 mm |
Skaana Management | 67.92 k | $2.31 mm |
CVI | 55.49 k | $2.35 mm |
Citadel Advisors | 11.95 k | $505.00 k |
UBS UBS Group AG - Registered Shares | 2.86 k | $97.00 k |
Rhumbline Advisers | 1.57 k | $7.62 mm |
Advisor | 316.00 | $1.52 mm |
Tower Research Capital | 99.00 | $475.00 k |
News
12 Health Care Stocks Moving In Thursday's Intraday Session
25 Apr 24
12 Health Care Stocks Moving In Tuesday's After-Market Session
9 Apr 24
Medigus Plans Corporate Rebranding, Changes Name To Xylo Technologies Ltd; Nasdaq Trading Symbol Will Change To 'XYLO'
9 Apr 24
Medigus Announces Its EV Joint Venture, Revoltz Initiates On Exclusive Distribution Agreement Of $2.7M In Revenues And Completes The Production Of The First 50 PORTO Micro-Mobility EVs
27 Mar 24
Press releases
Xylo Technologies Files its 2023 Annual Report on Form 20-F
22 Apr 24
Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its Business
9 Apr 24
Medigus: Revoltz Initiates on Exclusive Distribution Agreement of $2.7 Million in Revenues and Completes the Production of the First 50 PORTO Micro-Mobility EVs
27 Mar 24
Medigus: ParaZero Ramps Up Partnership with US-Based Autonomous Drone OEM Vayu Aerospace Corporation
22 Feb 24